Newsletter – January 2026

This issue explains recency bias, a phenomenon whereby investors let short-term performance influence their decisions, and ways to counter this, instead seeing the silver lining in market volatility.

This month we showcase three companies within the Booster Innovation Fund – Mars Bioimaging, Hot Lime Labs and MACSO Technologies. These companies are prime examples of high-potential, early-stage investment built on NZ innovation.

This month we unpack what a tariff is, and some of the ways we manage portfolios during uncertain times like this.

This month our theme is the OCR and how and why this is an important benchmark of an economy’s health.

This month we explain the two forces behind the rise in interest rates and how we can cushion the impact, and take advantage of opportunities as they arise.

Broadening Booster’s direct investments in attractive, unlisted NZ assets – Aotea Asset Management.